In Brazil, referral centers of the Brazilian AIDS Program across the country offering ART and access to LFA screening and preemptive antifungal therapy to patients with CD4 < 200 cells/μL are expected to support a continuous and sustained intervention to ensure surveillance in the prevention of CM and cryptococcal deaths. The gene discussed is CD4; the disease is AIDS.